@misc{indiciaeacd05659185b,
  title = {Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.},
  author = {S Mani and S Goel and M Nesterova and R M Martin and J M Grindel and M L Rothenberg and R Zhang and G Tortora and Y S Cho-Chung},
  year = {2003},
  doi = {10.1196/annals.1281.028},
  url = {https://pubmed.ncbi.nlm.nih.gov/14751840/},
  note = {Source identifier: 14751840}
}